AMOTIO LTD


Director	FOSTER, Iestyn


Registered Address	Springboard Business Innovation Centre Wales Llantarnam Park
	Cwmbran
	Torfaen
	NP44 3AW


Registered Number	15567127 (England and Wales)

Balance Sheet as at
31 March 2026

	2026 £	2025 £

Fixed Assets	29,272	35,038

Current Assets	41,467	79,132
Prepayments and accrued income	10,426	56,637
Creditors amounts falling due within one year	(55,685)	(8,412)
Net current assets (liabilities)	(3,792)	127,357

Total assets less current liabilities	25,480	162,395

Creditors amounts falling due after one year	(442,735)	(202,999)
Accruals and deferred income	-	(15,686)
Net assets (liabilities)	(417,255)	(56,290)
Capital and reserves	(417,255)	(56,290)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 5 (previous period: 3).
Additional Disclosures
The ultimate parent company is Amotio Health Ltd, whose bank balance at 31 March 2026 was £542,902. The company's principal activity is the research, development and manufacture (including outsourced manufacture), commercialisation, sale, distribution and marketing of medical devices — and related products and solutions — for the diagnosis and surgical treatment of disorders of the joints of the human skeleton, in particular (though not exclusively) the revision surgery of joint implants. Going concern The company is part of the well-funded Amotio group. Following the group's 2025 investment round, its parent, Amotio Health Limited, held cash funds of £542,902 at 31 March 2026 that are available to support the company's operations, and the company continues to attract non-dilutive grant funding, including a further instalment received since the year end. The directors have prepared cash flow forecasts, tested across a range of scenarios, which demonstrate that these group cash resources give the company a cash runway well in excess of twelve months from the date of approval; Amotio Health Limited has confirmed that the funds will remain available throughout that period. The company held net liabilities of £417,255 at 31 March 2026, consistent with its planned investment in product development. The directors are confident that the company has adequate resources to continue in operational existence for the foreseeable future, and the financial statements have accordingly been prepared on the going concern basis.

The financial statements were approved and authorised for issue by the Director on 29 April 2026, and are signed on its behalf by:

FOSTER, Iestyn
Director
Registered Company No. 15567127